Alkaline Ionized Water: Sports Recovery and Inflammation Management
NCT ID: NCT02748655
Last Updated: 2016-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
12 participants
INTERVENTIONAL
2016-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tap water
Oral consumption of tap water
Tap water
Alkaline ionized water
Oral consumption of alkaline ionized water
Alkaline ionized water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alkaline ionized water
Tap water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 25-40 years (inclusive)
* Body mass index (BMI) between 19.0 and 29.9 kg/m2 (inclusive)
* Not regularly exercising or participating in team sports.
Exclusion Criteria
* Diagnosed and medicated for diabetes
* Known serious chronic health condition
* Serious active illness within past 12 months
* Major surgery during past 8 weeks
* Alcohol consumption of more than four standard units/day (for example more than four regular 12-oz beers (5% alcohol), four small 5-oz glasses of wine (12% alcohol), or four 1.5 oz shots of 80-proof spirits) (or more than 28 per week);
* Regular use of marijuana products for the past three months
* Regular consumption of energy drinks
* Diagnosed with any blood clotting disorder or taking clotting factor concentrates.
* Taking any blood thinners or anticoagulants
* Taking anti-inflammatory medications on a daily basis (81 mg aspirin is acceptable)
* Diagnosed with high blood pressure or taking blood pressure medication
* Use of performance enhancing drugs within the last three months
* Having consumed prednisone (or related steroid medication) or received a prednisone injection within the last six months
25 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Natural Immune Systems Inc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gitte Jensen, Ph.D.
Research Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gitte S Jensen, PhD
Role: PRINCIPAL_INVESTIGATOR
Natural Immune Systems Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIS Labs
Klamath Falls, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS119004
Identifier Type: -
Identifier Source: org_study_id